Elephant Partners — 2023 Investments
1 investments dated 2023 · listed companies and verified rows first · show all
MellitusAug 2023SEC filingmedium confidence
BiotechBoston, US
Michael Chorev(Director)Jose Halperin(Director)Joyce Lonergan(Executive Officer)
Board seatChristopher De Souza· per SEC Form D · $750K raise · filed Aug 2023
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.